New Bone Grafting Technique in Paediatric Foot Surgery. Validation of Outcome Measures

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by University of Aarhus
Sponsor:
Collaborator:
Ceramisys
Information provided by (Responsible Party):
University of Aarhus
ClinicalTrials.gov Identifier:
NCT01770574
First received: September 26, 2012
Last updated: June 25, 2013
Last verified: June 2013
  Purpose

The purpose of this study is to determine whether artificial bone graft (ReproBone™) provides equally good results compared to autologous bone graft from the iliac crest and reduces postoperative pain.

To groups of patients (age 5-16) will be compared. One group randomized to autologous bone graft and the other group randomized to ReproBone™.

The evaluation will be based on pedobarography, Patient reported outcome assessment (Oxford Ankle Foot Questionnaire), pain (measured by visual analog scale) and radiographic stereo assay.


Condition Intervention
Pes Planovalgus
Device: ReproBone
Procedure: calcaneal lengthening

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: New Bone Grafting Technique in Paediatric Foot Surgery. Validation of Outcome Measures

Resource links provided by NLM:


Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Visual Analog Scale [ Time Frame: 12 hrs ] [ Designated as safety issue: No ]
    The pain will be assessed within the first 24 hrs


Secondary Outcome Measures:
  • Radiographic stereometric assay (RSA) [ Time Frame: The RSA will be taken at baseline and the final investigation at 12 months ] [ Designated as safety issue: Yes ]
    RSA wille be taken immediately postoperative, after 6 weeks, after 8 weeks, after 6 months and after 12 months. In this way the investigators will evaluate the healing progress and be able to assess eventual microluxation in the cuboideum relatively to calcaneus.


Other Outcome Measures:
  • Pedobarography [ Time Frame: preoperative, 6 months, 12 months ] [ Designated as safety issue: No ]
    Preoperative: The ambulatory examination prior to surgery. Pedobarography: The investigators use a pressure plate from Tekscan. The pressure of the patients feet is measures during stance and walking.


Estimated Enrollment: 30
Study Start Date: February 2013
Estimated Study Completion Date: January 2017
Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: ReproBone
calcaneal lengthening
Device: ReproBone
Artificial bone graft is inserted as a wedge in the calcaneal lengthening osteotomy
Other Name: Hydroxy-apatite-tricalcium-phosphate
Procedure: calcaneal lengthening
Autologous bone graft is harvested from the iliac crest and inserted as a wedge in the calcaneal lengthening osteotomy
Other Name: Autologous bone graft
Active Comparator: Autologous bone graft
calcaneal lengthening
Procedure: calcaneal lengthening
Autologous bone graft is harvested from the iliac crest and inserted as a wedge in the calcaneal lengthening osteotomy
Other Name: Autologous bone graft

Detailed Description:

Study C: HA-β TCP (ReproBone™) vs. autologous iliac crest bone graft in a calcaneal lengthening osteotomy in children with hindfoot valgus. A clinical randomized controlled study with 12 months of follow-up.

Purpose. To investigate the clinical and radiographic findings of a calcaneal lengthening osteotomy by comparing autologous bonegraft and HA-β-TCP graft in a group of children with hindfoot valgus deformities. The primary outcome measure is pain score (visual analog scale). We expect children who are randomized to HA-β-TCP graft to have less postoperative pain than children randomized to autologous bone graft.

Design. Prospective, randomized controlled study.

Randomization: Children who fulfill the criteria for inclusion together with their parents/guardian receive information about the project. The patients are randomized to respectively HA-ß-TCP and iliac crest bone graft.

Surgical procedure: Calcaneal lengthening osteotomy is performed between the anterior and middle facet of the subtalar joint. The corticalis of the calcaneus is bilaterally cut through. The planovalgus deformity is corrected and with a graft matching the wedged osteotomy is inserted. Tantalum balls are inserted into calcaneus on each side of the osteotomy and in cuboideum. Postoperative pain treatment consist of a tibial nerve catheter which is used the first 24 hours. Patients in whom graft is harvested from the iliac crest get local infiltration analgesics accordingly to a standardized procedure. The pain is registered by the use of a visual analog scale (VAS) a 3, 8 and 12 hours postoperative. The amounts of used analgesics are registered.

Power and significance: The primary parameter is postoperative pain score. We expect the use of artificial bone graft will reduce the VAS score from 60 mm to 30 mm. A reduction of 30 mm corresponds to a significant fall in pain intensity. With reference to a former published study on a comparable patient group we expect a standard deviation of 25 mm in the population. Therefore the number of patients in each group should be 12 in order to demonstrate a significant difference of 30 mm. We strive towards 2x15 patients in order to compensate for eventual drop-outs. We used an non-paired design with power = 80 % of p < 0.05%.

  Eligibility

Ages Eligible for Study:   5 Years to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children aged between 5-16 years with symptomatic planovalgus deformity admitted to the Department of Children's Orthopaedics, Aarhus University Hospital during the period 2012 to 2016. The surgical procedure is performed in about 10 children a year.
  • Pain and/or callosities.
  • Informed written consent from the child custody/guardianship.

Exclusion Criteria:

  • Children with soft bones (osteomalacia)
  • Children with cognitive impairment
  • Children with no ability to stand
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01770574

Contacts
Contact: Polina Martinekevich, MD PhD-student +4523742514 pmar@ki.au.dk

Locations
Denmark
Aarhus University Hospital Recruiting
Aarhus, Denmark, 8000
Contact: Polina Martinkevich, MD PhD-student    + 45 7846 4131    pmar@gmail.com   
Contact: Bjarne Møller-Madsen, DMSc    +45 20408025    bj.moma@gmail.com   
Principal Investigator: Polina Martinkevich, PhD-student         
Sponsors and Collaborators
University of Aarhus
Ceramisys
Investigators
Study Director: Bjarne Møller-Madsen, DMSc, Prof Department of Children's Orthopaedics Aarhus University Hospital
Principal Investigator: Polina Martinkevich, PhD-student Department of Children's Orthopaedics Aarhus University Hospital
Study Chair: Ole Rahbek, Assoc prof PhD MD Department of Children's Orthopaedics, Aarhus University Hospital
Study Chair: Martin Gottliebsen, MD PhD-stud Department of Children's Orthopaedics, Aarhus University Hospital
Study Chair: Maiken Stilling, MD, PhD Department of Orthopaedics, Aarhus University Hospital
Study Chair: Line Kjeldgaard Pedersen, MD, PhD Department of Children's Orthopaedics, Aarhus University Hospital
  More Information

No publications provided

Responsible Party: University of Aarhus
ClinicalTrials.gov Identifier: NCT01770574     History of Changes
Other Study ID Numbers: 1-10-72-250-12, Interventional
Study First Received: September 26, 2012
Last Updated: June 25, 2013
Health Authority: Denmark: Ethics Committee

Keywords provided by University of Aarhus:
calcaneal lengthening

Additional relevant MeSH terms:
Flatfoot
Foot Deformities
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on July 29, 2014